Here's Why Momentum in Monopar Therapeutics (MNPR) Should Keep going

Core Viewpoint - The article emphasizes the importance of confirming the sustainability of a stock trend through fundamental analysis and earnings estimates to enhance the likelihood of successful short-term investments [1][2]. Group 1: Stock Performance - Monopar Therapeutics Inc. (MNPR) has shown a significant price increase of 76.6% over the past 12 weeks, indicating strong investor interest [4]. - The stock has also increased by 9.2% in the last four weeks, suggesting that the upward trend is still intact [5]. - MNPR is currently trading at 81.8% of its 52-week high-low range, indicating a potential breakout opportunity [5]. Group 2: Fundamental Strength - MNPR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7]. Group 3: Investment Strategy - The "Recent Price Strength" screen is a useful tool for identifying stocks with strong fundamentals that can maintain their upward trends [3]. - The article suggests that investors should consider other stocks that pass through this screening process for potential investment opportunities [8].